{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Modular Phase I\/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5492, a T cell-engaging Antibody Targeting CD20 in Subjects with Relapsed or Refractory B-Cell Malignancies (TITANium)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-modular-phase-i-ii-open-label-dose-escalation-and-dose-expansion-study-to-evaluate-the-safety-pharmacokinetics-pharmacodynamics-and-efficacy-of-azd5492-a-t-cell-engaging-antibody-targeting-cd20\/#breadcrumbitem"}]}